Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome.
Study Design
- Tipo de estudio
- Review
- Población
- Restless legs syndrome patients
- Intervención
- Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome. None
- Comparador
- None
- Resultado primario
- None
- Dirección del efecto
- Neutral
- Riesgo de sesgo
- Unclear
Abstract
This article provides an updated practical guide for the treatment of primary restless legs syndrome (RLS). Articles that appeared after the American Academy of Neurology guideline search were reviewed according to the same evidence rating schedule. We found limited evidence for nonpharmacologic treatment options. In moderate to severe primary RLS, pharmacologic options may be considered, including iron suppletion, an α2δ ligand, a dopamine agonist, a combination of an α2δ ligand and a dopamine agonist, or oxycodone/naloxone. This article includes treatment options in case of augmentation.
TL;DR
This article provides an updated practical guide for the treatment of primary restless legs syndrome and includes treatment options in case of augmentation.
Used In Evidence Reviews
Similar Papers
Sleep medicine · 2004
Dopamine and iron in the pathophysiology of restless legs syndrome (RLS).
Neurology · 2004
Restless legs syndrome and pregnancy.
Movement disorders : official journal of the Movement Disorder Society · 2008
Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice.
Nature reviews. Neurology · 2010
Restless legs syndrome: pathophysiology, clinical presentation and management.
Sleep medicine · 2014
Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).
Sleep medicine · 2016